Leinco Technologies
Fenton
About Leinco Technologies
Leinco Technologies focuses on monoclonal antibodies and protein specialists for diagnostics, therapeutics, flow cytometry, and other research areas. Their innovative products and services augment the early discovery process in life science research, diagnostics, and groundbreaking development of protein therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Last round: Grant (Feb 2025)
- Website: leinco.com
- Phone: +1 636 326 2700
Industries & Categories
Biotechnology, Health Care, Life Science, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/leinco-technologies-153470 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.